Oppenheimer & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-966
| Closed | -$384K | – | 1688 |
|
|
2025
Q4 | $384K | Sell |
966
-750
| -44% | -$332K | 0.01% | 1174 |
|
|
2025
Q3 | $782K | Hold |
1,716
| – | – | 0.01% | 1012 |
|
|
2025
Q2 | $560K | Hold |
1,716
| – | – | 0.01% | 1097 |
|
|
2025
Q1 | $463K | Hold |
1,716
| – | – | 0.01% | 1097 |
|
|
2024
Q4 | $404K | Sell |
1,716
-190
| -10% | -$50K | 0.01% | 1149 |
|
|
2024
Q3 | $524K | Buy |
1,906
+190
| +11% | +$49.5K | 0.01% | 1018 |
|
|
2024
Q2 | $417K | Hold |
1,716
| – | – | 0.01% | 1066 |
|
|
2024
Q1 | $256K | Sell |
1,716
-2,663
| -61% | -$444K | ﹤0.01% | 1239 |
|
|
2023
Q4 | $838K | Sell |
4,379
-140
| -3% | -$23.8K | 0.02% | 770 |
|
|
2023
Q3 | $800K | Buy |
4,519
+93
| +2% | +$17.7K | 0.02% | 751 |
|
|
2023
Q2 | $841K | Buy |
4,426
+149
| +3% | +$29.5K | 0.02% | 773 |
|
|
2023
Q1 | $857K | Sell |
4,277
-47
| -1% | -$9.88K | 0.02% | 744 |
|
|
2022
Q4 | $1.03M | Buy |
4,324
+31
| +0.7% | +$6.61K | 0.02% | 671 |
|
|
2022
Q3 | $859K | Sell |
4,293
-763
| -15% | -$146K | 0.02% | 706 |
|
|
2022
Q2 | $738K | Buy |
5,056
+44
| +0.9% | +$6.24K | 0.02% | 790 |
|
|
2022
Q1 | $819K | Buy |
5,012
+2,169
| +76% | +$330K | 0.01% | 819 |
|
|
2021
Q4 | $482K | Buy |
2,843
+504
| +22% | +$93.7K | 0.01% | 1044 |
|
|
2021
Q3 | $441K | Hold |
2,339
| – | – | 0.01% | 1063 |
|
|
2021
Q2 | $397K | Hold |
2,339
| – | – | 0.01% | 1121 |
|
|
2021
Q1 | $331K | Hold |
2,339
| – | – | 0.01% | 1126 |
|
|
2020
Q4 | $304K | Buy |
2,339
+39
| +2% | +$5.21K | 0.01% | 1075 |
|
|
2020
Q3 | $335K | Hold |
2,300
| – | – | 0.01% | 943 |
|
|
2020
Q2 | $341K | Buy |
+2,300
| New | +$310K | 0.01% | 926 |
|
Other funds holding ALNY
VPM
VCM
